The Impact of Combined Risk-Reducing Gynecological Surgeries on Outcomes in DIEP Flap and Tissue-Expander Breast Reconstruction.

Plastic surgery (Oakville, Ont.) 2020 Vol.28(2) p. 112-116

Jayaraman AP, Boyd T, Hampton SN, Haddock NT, Teotia SS

관련 도메인

Abstract

[INTRODUCTION] In addition to prophylactic mastectomies, BRCA1 and BRCA2 mutation carriers are increasingly choosing to undergo risk-reducing procedures such as hysterectomies and salpingo-oophorectomies. Sometimes these surgeries are performed in the same visit as a mastectomy or a revisionary reconstruction procedure. Literature lacks descriptions of complications and trends for these combined surgeries.

[METHODS] Group 1 patients (n = 10, flaps = 20) had abdominal gynecologic procedures at the time of deep inferior epigastric artery perforator flap (DIEP flap) reconstruction. Group 2 patients (n = 29, breasts = 58) had gynecologic procedures at the time of mastectomy and tissue-expander placement. Group 3 patients (n = 141, breasts = 257) had mastectomy and tissue-expander reconstruction without gynecologic procedures and were used as a control group for group 2. Group 4 patients (n = 357, flaps = 673) had autologous breast reconstruction without gynecologic procedures and were used as a control for group 1. Categorical variables such as complications and flap loss were analyzed using χ tests. Continuous variables such as age, body mass index (BMI), operative time, length of stay were analyzed with 2-tailed tests. Multivariate analyses were run to control for group differences.

[RESULTS] Groups 1 and 4 were equivalent in age and comorbidities, except group 1 (32.8 kg/m) had significantly higher BMI than group 4 (31.4 kg/m), = .028. Average operating time was statistically equivalent for group 1 patients (610 minutes) and group 4 patients (503 minutes), = .289. Average hospital stay was equivalent as well (group 1 = 4.4 days, group 4 = 4.1 days, = .676). Operative times for group 2 patients (457 minutes) were significantly longer than for group 3 patients (288 minutes), < .01. Group 2 patients (3 nights) had significantly longer hospital stays than group 3 patients (2 nights), < .01. Group 1 patients (2/20 flaps, 10%) had a significantly higher rate of flap loss than group 4 patients (8/673 flaps, 1%), < .01. There were no differences in other flap complications. Additionally, there were no significant differences in postoperative tissue-expander complications between group 2 and group 3.

[DISCUSSION] Both flap losses in Group 1 patients occurred in a single patient with BMI = 39.3 kg/m and a personal history of recurrent DVTs. Additionally, the rates of complications across other measures were equivalent between groups. Thus, despite the increased rate of flap loss in Group 1 (10%) vs Group 4 (1.3%), along with the increased operative times and hospital stays, certain patients can be advised that a prophylactic gynecological procedure is safe to combine with breast reconstruction.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 flap 피판재건술 dict 6
해부 breast 유방 dict 3
시술 diep flap 피판재건술 dict 2
해부 abdominal scispacy 1
해부 breasts scispacy 1
합병증 salpingo-oophorectomies scispacy 1
합병증 flaps scispacy 1
약물 [INTRODUCTION] In scispacy 1
약물 [RESULTS] Groups 1 and 4 scispacy 1
질환 DIEP C0082274
diclofenac epolamine
scispacy 1
질환 8/673 scispacy 1
질환 DVTs C0151950
Deep thrombophlebitis
scispacy 1
기타 BRCA1 scispacy 1
기타 BRCA2 scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1
기타 DVTs scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문